These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1134191)

  • 1. Isolated rat hepatocytes as a model to study drug metabolism: dose-dependent metabolism of diphenylhydantoin.
    Inaba T; Umeda T; Mahon WA; Ho J; Jeejeebhoy KN
    Life Sci; 1975 Apr; 16(8):1227-32. PubMed ID: 1134191
    [No Abstract]   [Full Text] [Related]  

  • 2. Diphenylhydantoin metabolism by rat liver microsomes and some of the effects of drug or chemical pretreatment on diphenylhydantoin metabolism by rat liver microsomal preparations.
    Kutt H; Fouts JR
    J Pharmacol Exp Ther; 1971 Jan; 176(1):11-26. PubMed ID: 5569630
    [No Abstract]   [Full Text] [Related]  

  • 3. The metabolism of phenytoin by isolated hepatocytes and hepatic microsomes from male rats.
    Tsuru M; Erickson RR; Holtzman JL
    J Pharmacol Exp Ther; 1982 Sep; 222(3):658-61. PubMed ID: 7108769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of d-propoxyphene and diphenylhydantoin in rat liver microsomal preparation.
    Verebey K
    Res Commun Chem Pathol Pharmacol; 1978 Apr; 20(1):21-9. PubMed ID: 663405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of phenobarbital on plasma diphenylhydantoin level and metabolism in man and in rat liver microsomes.
    Kutt H; Haynes J; Verebely K; McDowell F
    Neurology; 1969 Jun; 19(6):611-6. PubMed ID: 5814306
    [No Abstract]   [Full Text] [Related]  

  • 6. Diphenylhydantoin metabolism. A prospective review.
    Glazko AJ
    Drug Metab Dispos; 1973; 1(5):711-4. PubMed ID: 4149711
    [No Abstract]   [Full Text] [Related]  

  • 7. Study of dose-dependent metabolism of 5,5-diphenyl-hydantoin in the rat using new methodology for isolation and quantitation of metabolites in vivo and in vitro.
    Gerber N; Weller WL; Lynn R; Rangno RE; Sweetman BJ; Bush MT
    J Pharmacol Exp Ther; 1971 Sep; 178(3):567-79. PubMed ID: 5571905
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on 5,5-diphenylhydantoin irreversible binding to rat liver microsomal proteins.
    Pantarotto C; Arboix M; Sezzano P; Abbruzzi R
    Biochem Pharmacol; 1982 Apr; 31(8):1501-7. PubMed ID: 7092941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model describing the disposition of phenytoin in isolated rat hepatocytes.
    Morais JA; Wagner JG
    Biopharm Drug Dispos; 1984; 5(4):357-76. PubMed ID: 6525443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of diphenylhydantoin by rat liver microsomes. I. characteristics of the reaction.
    Kutt H; Verebely K
    Biochem Pharmacol; 1970 Mar; 19(3):675-86. PubMed ID: 4396252
    [No Abstract]   [Full Text] [Related]  

  • 11. Measurement of effect of interferon on metabolism of diphenylhydantoin.
    Sonnenfeld G; Nerland DE
    Methods Enzymol; 1986; 119():715-8. PubMed ID: 2429163
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydroxylation of 5,5-diphenylhydantoin (phenytoin) by dog liver microsomes.
    Butler TC; Dudley KH; Mitchell GN; Johnson D
    Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):4-9. PubMed ID: 21639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreases in phenytoin hydroxylation activities catalyzed by liver microsomal cytochrome P450 enzymes in phenytoin-treated rats.
    Yamazaki H; Komatsu T; Takemoto K; Saeki M; Minami Y; Kawaguchi Y; Shimada N; Nakajima M; Yokoi T
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):427-34. PubMed ID: 11259327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake and metabolism of diphenylhydantoin in the isolated perfused rat liver.
    Inaba T; Umeda T; Endrenyi L; Mahon WA; Kalow W
    Biochem Pharmacol; 1978; 27(8):1151-8. PubMed ID: 697916
    [No Abstract]   [Full Text] [Related]  

  • 15. Felbamate in vitro metabolism by rat liver microsomes.
    Adusumalli VE; Wong KK; Kucharczyk N; Sofia RD
    Drug Metab Dispos; 1991; 19(6):1135-8. PubMed ID: 1687021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro hydroxylation of diphenylhydantoin and its inhibition by other commonly used anticonvulsant drugs.
    Patsalos PN; Lascelles PT
    Biochem Pharmacol; 1977 Oct; 26(20):1929-33. PubMed ID: 911347
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of diphenylhydantoin metabolism in rats and in rat liver microsomes by antitubercular drugs.
    Kutt H; Verebely K; McDowell F
    Neurology; 1968 Jul; 18(7):706-10. PubMed ID: 5691599
    [No Abstract]   [Full Text] [Related]  

  • 18. Stereoselective inhibition of diphenylhydantoin metabolism by p-hydroxyphenyl-phenylhydantoin enantiomers in rats.
    Huang JD; Hsieh CY
    Chirality; 1991; 3(6):454-9. PubMed ID: 1812955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postnatal development of phenytoin metabolic activity in rat liver microsomes.
    Blake DA; Cohen F; Miyasaki BC
    Drug Metab Dispos; 1978; 6(3):240-5. PubMed ID: 26543
    [No Abstract]   [Full Text] [Related]  

  • 20. Study of the stereoselectivity of the para-hydroxylation of diphenylhydantoin by the rat liver microsomal cytochrome P-450-dependent enzymes [proceedings].
    Cavalier R; Toussaint A; Cumps J
    Arch Int Physiol Biochim; 1978 May; 86(2):411-3. PubMed ID: 81000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.